Russia Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The Russian pharmaceuticals market had total revenues of $31.9 billion in 2022, representing a compound annual growth rate (CAGR) of 2.6% between 2017 and 2022.
0
According to in-house research, in 2022, Russia accounted for 9.02% of the European pharmaceuticals market. The growth in the pharmaceutical market is mainly due to an increase in pharmaceutical spending by the government toward the localization of drugs.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Russia
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts by both value and volume

Reasons to Buy

What was the size of the Russia pharmaceuticals market by value in 2022?
What will be the size of the Russia pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the Russia pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitors in Russia's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Are there any other notable players in the market?

8 Company Profiles

8.1. Novartis AG
8.2. Sanofi SA
8.3. Bayer AG
8.4. Les Laboratoires Servier

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Russia pharmaceuticals market value: $ billion, 2017-22
Table 2: Russia pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Russia pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Novartis AG: key facts
Table 5: Novartis AG: Annual Financial Ratios
Table 6: Novartis AG: Key Employees
Table 7: Novartis AG: Key Employees Continued
Table 8: Sanofi SA: key facts
Table 9: Sanofi SA: Annual Financial Ratios
Table 10: Sanofi SA: Key Employees
Table 11: Sanofi SA: Key Employees Continued
Table 12: Bayer AG: key facts
Table 13: Bayer AG: Annual Financial Ratios
Table 14: Bayer AG: Key Employees
Table 15: Bayer AG: Key Employees Continued
Table 16: Les Laboratoires Servier: key facts
Table 17: Les Laboratoires Servier: Key Employees
Table 18: Russia size of population (million), 2018-22
Table 19: Russia gdp (constant 2005 prices, $ billion), 2018-22
Table 20: Russia gdp (current prices, $ billion), 2018-22
Table 21: Russia inflation, 2018-22
Table 22: Russia consumer price index (absolute), 2018-22
Table 23: Russia exchange rate, 2018-22

List of Figures

Figure 1: Russia pharmaceuticals market value: $ billion, 2017-22
Figure 2: Russia pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Russia pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Russia, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Russia, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Russia, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Novartis AG
Sanofi SA
Bayer AG
Les Laboratoires Servier

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€344EUR$350USD£287GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€515EUR$525USD£431GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€687EUR$700USD£574GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Mid-Size Pharmaceuticals Global Market Report 2024

Pharmaceutical Suppositories Global Market Report 2024

Global Big Pharma Partnering Terms and Agreements 2020-2024

Botanical and Plant-Derived Drugs Market 2024-2028

Pharmaceuticals Market in Germany 2024-2028